CAPTIAM SYPHILIS-G ASSAY

Enzyme Linked Immunoabsorption Assay, Treponema Pallidum

TRINITY BIOTECH, PLC

The following data is part of a premarket notification filed by Trinity Biotech, Plc with the FDA for Captiam Syphilis-g Assay.

Pre-market Notification Details

Device IDK014233
510k NumberK014233
Device Name:CAPTIAM SYPHILIS-G ASSAY
ClassificationEnzyme Linked Immunoabsorption Assay, Treponema Pallidum
Applicant TRINITY BIOTECH, PLC IDA BUSINESS PARK BRAY Co. Wicklow,  IE
ContactFiona Campbell
CorrespondentFiona Campbell
TRINITY BIOTECH, PLC IDA BUSINESS PARK BRAY Co. Wicklow,  IE
Product CodeLIP  
CFR Regulation Number866.3830 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-12-26
Decision Date2002-01-24

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05391516744836 K014233 000
05391516744829 K014233 000
05391516746908 K014233 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.